NCT06810609 2026-01-27
InDuRanS
University Hospital, Bonn
Phase 2 Recruiting
Clinical Trials
8 trialsNCT07264647 2025-12-04
Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)
Fondazione Ricerca Traslazionale
Phase 2 Recruiting
NCT06998719 2025-05-31
ACCESS
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT01066234 2021-03-22
Adjuvant CCRT vs CT in Minimal N2 NSCLC
Samsung Medical Center
Phase 2 Completed
NCT03672136 2018-09-14
Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT00431613 2015-05-29
Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)
Hellenic Oncology Research Group
Phase 2 Terminated
NCT02215356 2014-08-13
Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd.
Phase 2 Unknown
NCT00490659 2007-06-25
Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes
Eli Lilly and Company
Phase 2 Completed